Spectracef promotions broaden antibiotic's indication, US FDA says
This article was originally published in Scrip
Executive Summary
The US FDA has warned Cornerstone Therapeutics that two sales aids for Spectracef (cefditoren pivoxil) broaden the cephalosporin antibiotic's approved indications and make unsubstantiated superiority claims.